SN

Swapna Nandy

Active Director Director DIN 01183705
DIN 01183705 First appointment Feb 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1994
Shareholding value •••• Premium profile

About Swapna Nandy

Data last updated:

Swapna Nandy is a Director at Genmed Pharma Pvt Ltd (since 1994). The company operates in Pharma. Genmed Pharma Pvt Ltd reported revenue of ₹23.7 Lakh (FY 2025).

DIN 01183705
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 1994
Oldest Company Age 32 yrs
Largest company Genmed Pharma Pvt Ltd · ₹23.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genmed Pharma Pvt Ltd U33112WB1994PTC061896
Director21 Feb 19941994₹23.7 Lakh (FY 2025)Active

Board colleagues of Swapna Nandy

NameDINCompanyDesignation
Ashoke Kumar Nandy01183710Genmed Pharma Pvt LtdDirector
Sujit Kumar Ghosh06407590Genmed Pharma Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Genmed Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Swapna Nandy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapna Nandy

Swapna Nandy currently holds 1 directorship: Genmed Pharma Pvt Ltd (Director, since 21 Feb 1994, revenue ₹23.7 Lakh (FY 2025)).

Swapna Nandy was first appointed on 21 Feb 1994 as Director at Genmed Pharma Pvt Ltd.

The current boards of Swapna Nandy's companies include Ashoke Kumar Nandy (Genmed Pharma Pvt Ltd), Sujit Kumar Ghosh (Genmed Pharma Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available